Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention
Status:
Terminated
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether catheter based ablation is better than
conventional anti-arrhythmic drug (AAD) therapy for reducing recurrent shocks in patients
with an implantable cardioverter defibrillator (ICD). The second purpose of the study is to
determine the safety of catheter-based ablation and the effect on quality of life of
patients.
The study hypothesis is that catheter ablation is superior to AAD therapy in preventing
recurrent ventricular arrhythmia in such subjects. This is a pilot trial which will provide
data regarding recruitment potential and the feasibility of conducting a larger trial.